Home/Filings/4/0001638599-16-000695
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001638599-16-000695

CIK 0000810509operating

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 5:24 PM ET

Size

5.4 KB

Accession

0001638599-16-000695

Insider Transaction Report

Form 4
Period: 2014-12-17
Regan William J.
SVP of lobal Regulatory Strate
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-12-17+25,00025,000 total
    Exercise: $1.50Exp: 2024-12-17Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]Option vests as to 6,250 shares upon grant, with balance vesting at the rate of 6,250 shares on January 28 in each of 2016, 2017 and 2018.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:24 PM ET
Size
5.4 KB